Calendar of upcoming scientific conferences

Home | Conference Management System | Conference Listings | Advertise | Contact | About
German French English
You are in: HomeConference ListingsHealthcare/Medicine → Oncology

Conference Management Software

Our Conference Management Software (COMS) can be used for online:

  • registration
  • payment
  • paper submission
  • review process
  • paper selection
  • production of the book of abstracts

Read more ...
Try our demo online

Conferences and Meetings on Oncology offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.


1.MBC — 5th Munich Biomarker Conference
 Dates 01 Dec 2015 → 02 Dec 2015
[ID=708588] Go to top of page
 LocationMunich, Germany
 Abstract Munich is one of Europe’s leading biotech locations with a strategic focus on the development of personalized medicine. The 5th Munich Biomarker Conference is organized by BioM and the internationally well connected Munich Biotech Cluster community. Though we bring together international experts from biotech and pharma industry with scientists and physicians. The programme covers all stages of biomarker development, from basic research to personalized treatment of patients. A focus lies on the translation of academic research findings into industry-driven drug development. A second core topic is the realization of individualized treatment in the standard of care. Measures of process development, companion diagnostics, precondition in regulatory and collaboration frameworks and financing or reimbursement will be discussed.
 Topics Latest technologies for biomarker discovery, Application of biomarkers in clinical practice, NGS for patient stratification and diagnosis, Epigenetics for drug development, Companion diagnostics development, Biomarker in drug development of rare diseases, Statistical evaluation of biomarkers, Digital transformation of health
 Related subject(s) Biotechnology; Genomics and Bioinformatics
2.Training — Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™
 Start date04 Dec 2015
[ID=717610] Go to top of page
 LocationNew Orleans, LA, United States
 Abstract Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ program is specifically designed for clinical oncologists, registered nurses, nurse practitioners, and the entire medical team involved in treating cancer patients with immunotherapy. These introductory, CME- and CNE-certified programs will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.
 Topics Immunology 101 for the Non-Immunologist, Basic Principles of Tumor Immunotherapy, Basic Mechanisms of Tumor Immune Suppression, Cytokines: Interferons, Interleukins and Beyond, Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies, Oncolytic Viruses as Tumor Immunotherapy Agents, Current Status of Chimeric and Adoptive T Cell Therapy, Is There a Role for Radiation Therapy and Immunotherapy?
 Contact Rosanne Stelpflug; Phone: [414-271-2456]; Email:
3.Expert Practice in Lung Cancer — Expert Practice in Lung Cancer
 Start date05 Dec 2015
[ID=749205] Go to top of page
 LocationBarcelona, Spain
 Abstract During this case-based meeting, leaders in the field will discuss in an interactive format clincial issues encountered daily by practicing physicians
 Topics Lung cancer, NSCLC, targeted therapy, next generation sequencing, NGS, tumor heterogeneity, radiotherepy, ALK inhibitor, SCLC, Mesothelioma
 Contact Victoria-Lou Deveze; Phone: [+31703067190]; Email:
 Related subject(s) Pulmonology
4.2nd Phuket International Symposium in Colorectal Disease 2015
 Dates 05 Dec 2015 → 07 Dec 2015
[ID=728752] Go to top of page
 LocationPhuket, Thailand
 Abstract Hosted by Bangkok-Phuket Colorectal Disease Institute in collaboration with Cleveland Clinic Florida and The American College of Surgeons (Thailand Chapter).
 Topics colorectal cancer, colonoscopy, robotics, laparoscopy, hemorrhoids, fistulas, symposium, Phuket
 Contact Teddy Ismael; Phone: [+66 (0)76 254425 ext 8609, 8607]; Email:
 Related subject(s) Gastroenterology
5.CTC — Combination Therapies in Cancer Conference: Tools and Techniques for Developing Combinations More Efficiently
 Dates 06 Dec 2015 → 09 Dec 2015
[ID=731464] Go to top of page
 LocationBudapest, United Kingdom
 Abstract There is a growing realization that the rational design and optimization of combination therapies is critical to achieving practical successes in the field of Oncology. The heterogeneous and evolving nature of tumors in the clinical setting serves to readily defeat single-agent targeted therapies. The traditional paradigm of selecting combinations based on synergy in preclinical experiments sidesteps the fundamental challenge of Oncology combination development- will the combination possess a broader therapeutic window than each drug alone? In this conference, we will discuss ways in which this critical challenge can be addressed in a targeted manner.
 Topics Biology of novel combinations, case studies in preclinical and clinical development of combinations, optimizing combination design using mathematical modeling (schedule selection, dose optimization and indication selection), development of multidrug cocktails (techniques and case studies).
 Contact Laura Trundle; Phone: [(+44 (0)1638 724137)]; Email:
 Related subject(s) Clinical trials
6.Nutrition — Nutrition and Survivorship: Nutritional issues following cancer treatment
 Start date08 Dec 2015
[ID=728928] Go to top of page
 LocationSouth Kensington, London, United Kingdom
 Topics Nutritional issues following head and neck cancer; Nutritional issues and effects on quality of life after surgery for upper GI; Nutrition and survivorship following treatment for colorectal cancer; Gastrointestinal consequences of treatment - a Dietetic approach; Survivorship issues following treatment for gynaecological cancer; Nutritional issues following treatment for prostate cancer; Long term nutritional consequences of leukaemia and its treatment: Paediatric and adult perspectives;
 Contact The Conference Team; Phone: [02078082921/4]; Email:
 Related subject(s) Agronomy, Food Production and Food Chemistry; Nursing and Midwifery
7.The 2015 San Antonio Breast Cancer Symposium
 Dates 08 Dec 2015 → 12 Dec 2015
[ID=641670] Go to top of page
 LocationSan Antonio, Texas, United States
 Related subject(s) Radiology: Mammography
8.Training — Developing Effective Cancer Survivorship Services
 Start date10 Dec 2015
[ID=743127] Go to top of page
 LocationLondon, United Kingdom
 Organizer Healthcare Conferences UK
 Abstract This conference focuses on cancer survivorship, improving outcomes for people living with and beyond cancer, moving from surviving to thriving. Through national updates and practical case studies the conference aims to support you to develop effective cancer survivorship support and services. A 20% discount s available by quoting ref: HCUK20C-S when booking.
 Topics Cancer
 Contact Kerry Tarrant, Healthcare Conferences Uk, 8 Wilson Drive, Ottershaw, Surrey KT16 0NT; Phone: 0044/1932 429933; Email:
 Related subject(s) Medicine (in general)
9.Pain Management — National Acute Pain Management Study Day
 Start date13 Jan 2016
[ID=728887] Go to top of page
 LocationSouth Kensington, London, United Kingdom
 Topics Pain Assessment; Pain Physiology in relation to pharmacological action; Procedure related to acute pain management; cancer treatment related to acute pain management; Impact of Enhanced recovery pathway on acute pain management; Peri-operative Pain Management; Acute pain management in the patient with complex/chronic pain; Management of Paediatric acute pain;
 Contact Conference Team; Phone: [(02078082921/4)]; Email:
 Related subject(s) Nursing and Midwifery ; Healthcare Systems
10.CDDF – ITCC – SIOPE 4th Paediatric Oncology Conference
 Dates 20 Jan 2016 → 21 Jan 2016
[ID=737746] Go to top of page
 LocationBrussels, Belgium
 Abstract The Cancer Drug Development Forum, in partnership with ITCC and SIOPE, is organising the 2016 edition of the high-level Paediatric Oncology Conference ‘Accelerating the Development of New Oncology Drugs for Children and Adolescents’. This is the fourth meeting of an ongoing series of biennial conferences aiming at promoting progress in the field of paediatric oncology drug development through input from all concerned stakeholders: regulatory bodies, academia, the pharmaceutical industry, parents and policymakers.
 Topics New strategies for improved development of oncology drugs for children and adolescents, Mechanism of action based development strategy, Compound prioritization, Changes needed in the paediatric medicine regulation, New incentives for specific paediatric drug development and drug repositioning, Implementation of long-term follow up measures of children and adolescents receiving new anticancer drugs, Recent successes in new drug development will be shared.
 Contact Marjorie Recorbet; Phone: [+32 (0) 2 775 02 15]; Email:
 Related subject(s) Pediatrics
11.Gynecology Oncology Conference — 2016 Progress and Controversies in Gynecologic Oncology Conference
 Dates 22 Jan 2016 → 23 Jan 2016
[ID=728526] Go to top of page
 LocationBarcelona, Spain
 Abstract This meeting will serve as a valuable forum for the presentation and discussion of newly available data across various gynecologic malignancies, including ovarian, cervical, and endometrial cancers. Participants will be provided with updates on practice-changing data in a practical and interactive format, fostering discussion, and impacting clinical outcomes for patients.
 Topics oncology, gynecology, controversies, radiation therapist, surgeons, pahtologists, gynecologist
 Contact Phone: [+31703067190]; Email:
 Related subject(s) Obstetrics/Gynecology
12.PMWC — Personalized Medicine World Conference
 Dates 24 Jan 2016 → 27 Jan 2016
[ID=722866] Go to top of page
 LocationSilicon Valley, United States
 Abstract The Personalized Medicine World Conference (PMWC) is an independent and established Silicon Valley conference founded in 2009 and has hosted nine conferences around the world, most recently at Oxford University. Co-hosted with Stanford Health Care, PMWC 2016 Silicon Valley will gather close to 1200 multidisciplinary attendees and key stakeholders from the business, government, healthcare delivery, research and technology arenas to examine the advances and challenges of personalized medicine through a practical lens.
 Topics Genomic Profiling, NGS, Cancer Immunotherapy, Prenatal Dx, Clinical Trials in Personalized Medicine (PM), Biomarker Discovery, Coverage & Reimbursement, Cloud Technologies, Population Genomics, Pharma Perspective on PM
 Contact Kelly Huggins; Email:
 Related subject(s) Biotechnology; Medicine (in general)
13.Keystone Symposia: Cancer Immunotherapy – Immunity and Immunosuppression Meet Targeted Therapies
 Dates 24 Jan 2016 → 28 Jan 2016
[ID=738939] Go to top of page
 LocationVancouver, British Columbia, Canada
 Abstract This meeting focuses on immune escape mechanisms, immune tolerance, the role of immune effector and suppressor cells as well as the tumor microenvironment in this context, and the modulation of these different processes. In addition, the modes and efficacy of different cancer immunotherapeutic strategies and targeted therapies alone and in combination as well as their influence on the immune escape and immune suppressive activity will be an important topic. This meeting is expected to attract a broad range of scientists (e.g., biologists, biochemists, immunologists, cancer researchers) and clinicians (oncologists, pathologists, radiologists) and will bridge basic, translational and clinical research. The speakers invited represent basic researchers, clinicians and employees of the pharmaceutical industry. There will be a strong clinical focus to the program, in particular regarding different therapeutic strategies including cancer immunotherapy and targeted therapies, which have recently been successfully implemented for the therapy of many cancers including chronic myeloid leukemia, breast carcinoma, non-small lung carcinoma, colorectal cancer, kidney cancer and melanoma. This meeting is being held in conjunction with "Purinergic Signaling."
 Topics Cancer Immunology Cell Biology
 Contact Attendee Services; Phone: [+1 970-262-1230 or 800-253-0685]; Email:
 Related subject(s) Biology; Human Physiology and Metabolism
14.IO360 — Immuno-Oncology 360°
 Dates 02 Feb 2016 → 03 Feb 2016
[ID=765685] Go to top of page
 LocationNew York, United States
 Abstract Immuno-Oncology 360° is the only conference that combines business and clinical development strategies with scientific updates to prepare the market for accelerating immuno-oncology (IO) clinical trials. With rapid development of cancer immunotherapy drug development, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce. The science behind immune-based therapies is driving rapid change. Both small and large companies are racing to bring game-changing therapies to the market and in many cases, partnering to maximize on combination therapies. As a result, innovative approaches and developments are also creating increased momentum for investment/business development opportunities.
 Topics Clinical Development, Immuno-Oncology, Emerging Biomarkers, Immunotherapy
 Contact Marianne Arthur; Email:
15.The Cancer Genome
 Dates 07 Feb 2016 → 11 Feb 2016
[ID=739980] Go to top of page
 LocationBanff, Canada
 Abstract The combination of next-generation sequencing and analysis as applied to experiments studying the cancer genome has revolutionized our understanding of cancer biology. Large-scale cancer genomics has further established a baseline that is now poised to effect the translation of cancer genomics into the clinical setting, effectively transforming patient care. The barriers and challenges to translation are significant, not the least of which involves the transition of research-grade computational and interpretational analysis to clinical-grade analysis. Assays must be highly refined, validated and accurate. How the use of genomic approaches to monitor patient response to therapy, the onset of acquired resistance to therapy and other aspects of patient care will be accepted as a more sensitive partner with conventional imaging approaches must be addressed. Appropriate assignment of therapies to specific gene/protein alterations also will be of paramount importance, especially as the numbers and types of targeted therapies increase. Genomics will also impact our understanding of the immune system's interaction with tumors, leading to the development of personalized vaccine strategies that may provide more durable responses.
16.Genomics and Personalized Medicine
 Dates 07 Feb 2016 → 11 Feb 2016
[ID=740067] Go to top of page
 LocationBanff, Canada
 Abstract Genomics and other omics technologies are playing an increasingly important role in health care, and new sensors are being developed to help manage personal health. Spurred by the revolution in DNA sequencing technologies, it is now possible to sequence the genome of patients with cancer, undiagnosed disease and even healthy individuals to help tailor treatment for a specific individual’s disease. This entire area is moving extremely rapidly in terms of technology, data, its management and analysis, and clinical uptake. The goal of this meeting is to bring together leaders in technology development, basic scientists, engineers and clinicians to advance human health. It intends to: 1) Help researchers and clinicians keep abreast of the latest developments; 2) Stimulate collaborations; and 3) Spur the development of new technologies that will improve personalized medicine. This meeting is being held jointly with  The Cancer Genome.
 Related subject(s) Genomics and Bioinformatics
17.ADC EU — World ADC Berlin 2016
 Dates 08 Feb 2016 → 10 Feb 2016
[ID=762647] Go to top of page
 LocationBerlin, Germany
 Abstract Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research. Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.
 Topics adc, antibody, drug, conjugate, conjugates, antibody drug conjugates
 Contact Charlotte Parnaby; Phone: [+44 (0)20 3141 8700]; Email:
 Related subject(s) Pharmacology and Drug Development
18.NEO 16 — “New and Emerging Trends In Oncology 2016?
 Dates 10 Feb 2016 → 12 Feb 2016
[ID=738352] Go to top of page
 LocationHyderabad, India
 Abstract The International Conference “New and Emerging Trends In Oncology 2016? (NE0’16) is an initiative by Herbert Publications to provide a unique multidisciplinary environment for all science and research professionals with a common interest in Cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape.
 Topics Cancer Biology Organ Specific Cancer Anti Cancer Drugs Radiation Therapy Cancer Markers Cancer Immunology
19.Noncoding RNAs in Health and Disease
 Dates 21 Feb 2016 → 24 Feb 2016
[ID=740119] Go to top of page
 LocationSanta Fe, United States
 Abstract Over the past decade, there has been a greater understanding of genomic complexity in eukaryotes ushered in by the immense technological advances in high-throughput sequencing of DNA and its corresponding RNA transcripts. This has resulted in the realization that beyond protein-coding genes, there are a large number of transcripts that do not encode for proteins and, therefore, may perform their function through RNA sequences and/or through secondary and tertiary structural determinants. This Keystone Symposia meeting is focused on the latest findings concerning different classes of noncoding RNAs that use different strategies to regulate transcription. These are exciting times for discovering the biological scope and the mechanism of action for these RNA molecules, which have roles in dosage compensation, imprinting, enhancer function and transcriptional regulation, with a consequently great impact in development and disease. This meeting is being held jointly with  Enhancer Malfunction in Cancer.
 Related subject(s) Genomics and Bioinformatics
20.Enhancer Malfunction in Cancer
 Dates 21 Feb 2016 → 24 Feb 2016
[ID=740129] Go to top of page
 LocationSanta Fe, United States
 Abstract Why point mutations in a general transcription factor are associated with specific forms of human malignancies has been a major question in cancer biology. Enhancers are DNA regulatory elements that can be transcribed and are key regulators of tissue-specific gene expression in development; their malfunction through point mutations in either regulatory elements or factors modulating enhancer-promoter communication could result in development problems. Indeed, recent genome-wide studies in the cataloging of somatic mutations in cancer have identified mutations in intergenic sequences encoding regulatory elements and in specific transcription factors that function in enhancer-promoter communication. This Keystone Symposia meeting will review recent reports in this regard and discuss the concept of enhancer malfunction in the misregulation of gene expression in development and in disease pathogenesis. This meeting is being held jointly with  Noncoding RNAs in Health and Disease.
 Related subject(s) Genomics and Bioinformatics
21.New Frontiers in Understanding Tumor Metabolism
 Dates 21 Feb 2016 → 25 Feb 2016
[ID=740084] Go to top of page
 LocationBanff, Canada
 Abstract This meeting will bring together experts in the field as well as newcomers, who are expected to enrich the conceptual framework for the study of tumor metabolism. Sessions are designed to bring the latest in basic biochemical work in metabolism to biologists, to deliver new findings in oncogenic transcriptional and post-transcriptional regulation of metabolism as a basis for further basic biochemical discoveries, and to provide foundational findings that lead to therapeutic applications of tumor metabolism research. The goals of these sessions are to: 1) Discuss new discoveries of previously unsuspected metabolic re-wiring in cancer, 2) Present current findings in transcriptional and post-transcriptional regulation of tumor metabolism and future challenges, and 3) Provide an update on opportunities for cancer therapy using knowledge generated from fundamental discoveries. New methods and knowledge will be shared at the meeting. This meeting is being held jointly with  Immunometabolism in Immune Function and Inflammatory Disease.
22.Immunometabolism in Immune Function and Inflammatory Disease
 Dates 21 Feb 2016 → 25 Feb 2016
[ID=740094] Go to top of page
 LocationBanff, Canada
 Abstract It is now evident that an integral component of immune regulation is through the metabolic pathways necessary to support energetically demanding protective or pathogenic responses. Deciphering these links in the emerging field of immunometabolism is critical to understanding basic immune function. Activation, differentiation and function of M1 & M2 macrophages, Th1, Th2, Th17 & T regulatory T cells as well as effector and memory CD8 T cells are all inexorably linked to pathways that regulate cellular metabolism. Likewise, systemic metabolism and metabolic diseases are very much influenced by immunity, as the metabolic syndrome in obesity is mediated in part by dysregulated immune cells similar to inflammatory and autoimmune disease states. This meeting addresses how immune cells and functions rely upon and are controlled by specific metabolic pathways and nutrient availability and will bridge systemic and cellular metabolic regulation of immune function. Metabolic reprogramming in the activation of adaptive and innate immune cells and the regulation and role of specific metabolic programs in distinct lymphocyte or macrophage subsets will be addressed. The conference will also present new findings on signaling pathways and the influence of immune cell metabolism on anti-tumor immunity, autoimmunity and metabolic diseases. It is anticipated this meeting will be of broad interest to the immunology and metabolic communities. The focus of this meeting on how factors that influence immune cell metabolism impact a variety of inflammatory disorders will provide new fundamental insight into normal immune function as well as opportunities to treat immunological and metabolic diseases. This meeting is being held jointly with  New Frontiers in Understanding Tumor Metabolism.
 Related subject(s) Human Physiology and Metabolism
23.Precision: Breast Cancer World Summit 2016
 Dates 23 Feb 2016 → 24 Feb 2016
[ID=764696] Go to top of page
 LocationBoston, United States
 Abstract Over the two days, this exclusive summit will bring together 80-100 senior level attendees from the pharmaceutical industry and academia to discuss the most crucial challenges in the development of targeted therapies in Breast Cancer.
 Topics Antibody Constructs, Antibody Drug Conjugates, Immuno-Oncology, Biomarkers and Companion Diagnostics.
 Contact Grace Hamilton; Email:
24.DKK 2016 — 32. Deutscher Krebskongress Berlin 2016
 Dates 24 Feb 2016 → 27 Feb 2016
[ID=746242] Go to top of page
 LocationBerlin, Germany
 Abstract Der Deutsche Krebskongress (DKK) ist der größte und bedeutendste Fachkongress zur Krebsdiagnostik und Krebstherapie im deutschsprachigen Raum. Er wird von der Deutschen Krebsgesellschaft und der Deutschen Krebshilfe gemeinsam ausgerichtet. - Aktuelles zu allen häufigen und vielen seltenen Krebserkrankungen - Vorstellung aller neuen Leitlinien - Interaktive Tumorkonferenzen - Aktuelle gesundheitspolitische Themen
 Topics Kongressmotto: MEDIZIN HEUTE: präventiv, personalisiert, präzise und partizipativ
 Contact Kongress- und Kulturmanagement GmbH; Phone: [+49 3643 2468-0]; Email:
25.12th UC San Diego Moores Cancer Center Industry/Academia Translational Oncology Symposium
 Start date25 Feb 2016
[ID=762892] Go to top of page
 LocationLa Jolla, California, United States
 Abstract The annual Industry/Academia Translational Oncology Symposium at Moores Cancer Center, now celebrating its 12th year, was created to support multi-modality collaborations and foster new partnerships in order to speed new therapies to patients. Each year the Symposium’s esteemed presenters from around the world, including clinicians, researchers, and top decision makers from industry and academia, attest to just how necessary it was for them to surmount multiple obstacles, in and out of the lab, in order to achieve success and help patients. The forum provides a platform for oncology innovators to highlight their interdisciplinary approach, as opposed to discussion on a specific type of cancer. Case study presentations showcase successful efforts, the challenges that they encountered, and the lessons they have learned from the process.
 Topics Immunotherapy, Precision medicine, New therapeutic approaches in numerous cancers, Orphan drug oncology indications, Innovative clinical trial modalities, Funding innovation
 Contact Leisa Sutton; Phone: [858-822-6582]; Email:
 Related subject(s) Clinical trials; Hematology
26.Cancer Vaccines: Targeting Cancer Genes for Immunotherapy
 Dates 06 Mar 2016 → 10 Mar 2016
[ID=739946] Go to top of page
 LocationWhistler, Canada
 Abstract The past decade has seen tremendous developments in novel cancer therapies, through targeting of tumor cell-intrinsic pathways whose activity is linked to genetic alterations, as well as the targeting of tumor cell-extrinsic factors such as growth factors. Remarkable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies, possibly due to the lack of T cell repertoire with specificity against cancer antigens. This creates the need for effective means of expanding the T cells in patients via immunization, i.e., cancer vaccines. Much progress has been made in recent years in this regard, and several phase III clinical trials testing various approaches to therapeutic vaccination are ongoing. The challenge for next-generation vaccines is to resolve the discrepancy between the immune and clinical efficacy measured by the rate of cancer rejection. The future immunotherapy of cancer lies in combination approaches targeting T cells as well as cancer genes to combat underlying inflammation. Spectacular progress has been made in these two parallel fields, i.e., cancer genomics and genetics and tumor immunology. It is time now to link these fields to enable the linking of genetic alterations with the type of immune response. The meeting will therefore host cancer geneticists, cancer biologists, experts in cancer antigen presentation, tumor immunologists and vaccinologists. It will discuss the immunological basis for therapeutic cancer vaccines and how the current understanding of cancer genomics, antigen presentation and T cell biology might enable development of next-generation curative therapies for patients with cancer. This meeting will be held jointly with  Antibodies as Drugs.
27.Antibodies as Drugs
 Dates 06 Mar 2016 → 10 Mar 2016
[ID=740137] Go to top of page
 LocationWhistler, Canada
 Abstract Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation. This meeting is being held jointly with  Cancer Vaccines: Targeting Cancer Genes for Immunotherapy.
 Related subject(s) Pharmacology and Drug Development
28.Stem Cells and Cancer
 Dates 06 Mar 2016 → 10 Mar 2016
[ID=740037] Go to top of page
 LocationBreckenridge, United States
 Abstract Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses both tremendous challenges and tantalizing potential for our ability to successfully combat cancer. This Keystone Symposia meeting aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. One area of emphasis will be intercellular communication. Cellular context and microenvironment establish the tumor niche and shape the interaction of the tumor with the immune system. In addition, developmental signal transduction pathways such as Hippo, Notch and Wnt, frequently deregulated in cancer, increasingly offer tangible opportunities for therapeutic intervention. Another important area of emphasis will be efforts to better understand the mechanisms and importance of tumor heterogeneity. Techniques such as clonal analysis and barcoding are shedding important light on the interplay between tumor evolution, differentiation, miRNA control and epigenetics. This is an era of rapid progress in understanding cancer stem cell biology with great potential to benefit human health. 
 Related subject(s) Human Physiology and Metabolism
29.Changing Prospects for Cancer 'A good survival'
 Start date11 Mar 2016
[ID=737728] Go to top of page
 LocationManchester, United Kingdom
 Abstract Since the publication of the National Cancer Survivorship Initiative “Visioning” paper in 2010, the momentum behind improving  services for patients living with and beyond cancer has increased exponentially. The challenge for the next few years is to facilitate  implementation of these innovations into mainstream cancer services. In April 2014, The Christie, Macmillan Cancer Support and University  of Salford joined forces to hold a conference discussing and debating  the challenges, issues and controversies related to an increasing  population of cancer survivors. Join us on 11th March 2016 where  we will pick up the discussions at an interactive and discussion filled  conference
30.Biomarker Summit 2016
 Dates 21 Mar 2016 → 23 Mar 2016
[ID=744556] Go to top of page
 LocationSan Diego, United States
 Abstract The Biomarker Summit 2016, to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel
 Topics Oncology Biomarkers, Neurological Biomarkers, Inflammatory & Immunological Biomarkers
 Contact Kristen Starkey; Phone: [6262566405]; Email:
 Related subject(s) Biology; Pharmacology and Drug Development
31.Cancer Pathophysiology: Integrating the Host and Tumor Environments
 Dates 28 Mar 2016 → 01 Apr 2016
[ID=740069] Go to top of page
 LocationBreckenridge, United States
 Abstract The local and systemic tumor microenvironments (TME) play a pivotal role in all stages of cancer development, including initiation, malignant conversion and metastasis, as well as regulating how neoplastic cells respond to cytotoxic, targeted and immune-based therapies. Research over the last decade has revealed the incredible diversity and plasticity that constitute the TME. Thus, the focus of this meeting will be to bring together a wide breadth of experts who focus on the various aspects of the TME with the intent of creating a more complete picture of the potential therapeutic landscape. The unique feature of this meeting is its breadth of experts focused on both the systemic and local TME, who also recognize varied paracrine interactions with heterogeneous neoplastic cells. Presentations will focus on emerging studies to enable attendees access to senior investigators, as well as new investigators spanning the diversity of disciplines called “cancer biology.” In addition to invited speakers, time will be allotted for short oral presentations selected from submitted abstracts and three integrated poster sessions. 
32.EMBO | EMBL Symposium — EMBO | EMBL Symposium: Tumour Microenvironment and Signalling
 Dates 03 Apr 2016 → 06 Apr 2016
[ID=724192] Go to top of page
 LocationHeidelberg, Germany
 Abstract Many oncogenes and tumor suppressor genes have been identified and mapped to signaling pathways that regulate cell growth and death. Dysregulation allows oncogenes and tumor suppressor genes to transform mammalian cells and cancers arise in conditions where multiple such events occur in the same cell. Many proto-oncogenes and tumor suppressors have been mapped to canonical signaling pathways, providing a more holistic view of growth control mechanisms and paving the way for systems level analysis of cancer mechanisms.It has also been found that a subset of the cells present in a tumor, called cancer stem cells, retain the ability to self-renew and to give rise to all cell types in a particular cancer. An emerging concept is that tumors also strongly depend on external signals for maintenance and expansion. To fully understand tumor development and progression, a deeper knowledge of the cross-talk between tumor cells and their microenvironment and the interactions between cancer cells and cancer stem cells is needed. Aims of event This symposium brings together researchers from complementing fields to enhance our understanding of the communication between cancer cells and their microenvironment. Important open questions are: Which signals do cancer cells transmit to and receive from the stroma and how do these signals promote malignant growth? What roles does the extracellular matrix play during neoplastic transformation? What is the contribution of immune cells to tumor progression? How is the inflammatory response of the tumor microenvironment regulated by the microbiota?
 Topics Signalling pathways in stroma and cancers, Cancer stem cells, Cancer and the immune system, Animal models of cancer, Therapeutical implications: from bench to bedside
 Contact Email:
 Related subject(s) Biology; Molecular Biology
33.Cancer-2016 — International Cancer Study & Therapy Conference
 Dates 04 Apr 2016 → 06 Apr 2016
[ID=742888] Go to top of page
 LocationBaltimore, United States
 Abstract International Cancer Study & Therapy Conference (Cancer-2016) is going to be held during April 4-6, 2016 at Baltimore, USA. Cancer 2016 bring upon a new platform to share and discuss all the innovations in the cancer diagnosis and treatment.
 Topics Cancer Etiology and Epidemiology • Organ Specific Cancers and Effects • Clinical Research • Vaccines and Cancer Prevention Mechanisms • Cancer Immunology • Cancer Genetics Risk Assessment • Radiation, Surgical and Medical oncology • Structural Biology and Biomarkers • Diagnostic methods for cancer treatment Please mail us at: Submit your abstracts at:
 Contact Jennifer Roy; Phone: [+1-302-231-6959]; Email:
34.26th Annual Interdisciplinary Breast Center Conference
 Dates 09 Apr 2016 → 13 Apr 2016
[ID=760752] Go to top of page
 LocationLas Vegas, United States
 Contact Michelle Dearlove; Phone: [(574-401-8113)]; Email:
 Related subject(s) Radiology: Mammography
35.APOCP — General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention
 Dates 13 Apr 2016 → 16 Apr 2016
[ID=650952] Go to top of page
 LocationBrisbane, Australia
 Abstract Asian Pacific Organisation for Cancer Prevention (APOCP) is a non-political, non-profit organisation to promote cancer prevention and collaborative studies in the Asia Pacific region. The aims of APOCP are to provide opportunities for expert researchers to exchange mutual information for cancer prevention, to promote collaborative studies on cancer epidemiology and prevention, and to facilitate the implementation of active programs for cancer prevention. The General Assembly and Conference is APOCP’s regional biennial summit, drawing highly influential delegates together to guide the organisation’s action agenda.
36.AACR Annual Meeting
 Dates 16 Apr 2016 → 20 Apr 2016
[ID=615359] Go to top of page
 LocationNew Orleans, Louisiana, United States
 Organizer American Association for Cancer Research
37.Oncology-2016 — World Congress and Expo on Oncology & Radiology
 Dates 18 Apr 2016 → 20 Apr 2016
[ID=766135] Go to top of page
 LocationDubai, United Arab Emirates
 Topics Cancer Cell Biology & Biomarkers, Advances in Cancer Detection, Imaging, Management & Prevention, Organ-Specific Cancers and Cancer Genetics, Anti-Cancer Drug Discovery and Development, Novel Approaches to Cancer Therapeutics, Cancer Therapy and Clinical Cancer Research, Socio-Economic Impact of Cancer, Ayurvedic Treatment for Cancer
 Contact Vijay Kumar; Phone: [7799790001]; Email:
 Related subject(s) Radiology (in general); Radiology: Nuclear Magnetic Resonance Imaging
38.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity
 Dates 21 Apr 2016 → 25 Apr 2016
[ID=738361] Go to top of page
 LocationVaradero, Cuba
 Abstract The four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of disease pathogenesis and new targeted therapies development for Cancer and for Autoimmune Disorders. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research. One of the key objectives of the 2016 Symposium will be to arm delegates with the necessary tools that will enable them to make a difference, implement and take actions at all levels, in global fight against cancer or autoimmunity diseases.
 Topics Molecular oncology; Tumor immunology; Cancer Immunotherapy, Clinical trials; Mechanisms of autoimmune-related diseases; Regulatory T cells and autoimmunity; Pharmacological strategies for treatment
 Contact Jesus Benitez; Email:
 Related subject(s) Pharmacology and Drug Development
39.The 2nd World Congress on Controversies in Multiple Myeloma (COMy)
 Dates 28 Apr 2016 → 30 Apr 2016
[ID=757148] Go to top of page
 LocationParis, France
 Abstract The 2nd COMy Congress will bring to the forefront the latest and most controversial data and information in the field of Multiple Myeloma, providing a unique opportunity for world class leaders in the field to debate vital and contentious issues in Myeloma. This thought-provoking academic dialogue will address the most challenging current clinical and therapeutic questions.
 Topics Myeloma, Oncology, Hematology, Therapy, Treatment
 Contact Natalie Ross; Phone: [97235666166]; Email:
 Related subject(s) Hematology
40.6th International Symposium on Hereditary Breast and Ovarian Cancer
 Dates 10 May 2016 → 13 May 2016
[ID=727516] Go to top of page
 LocationMontreal, Canada
 Abstract “BRCA: Challenges and Opportunities – the Sixth International Symposium of Hereditary Breast and Ovarian Cancer ” represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.      It is an accredited continuing educational activity for physicians and genetic counselors.   This is THE major international conference in the world that covers specific targeted therapies for hereditary cancer. Clinicians and researchers from over 25 countries will gather for the sixth edition of this event which has come to be recognized as one of the leading international scientific conferences on hereditary breast and ovarian cancer.
41.Controlling Cancer Summit 2016
 Dates 17 May 2016 → 19 May 2016
[ID=737366] Go to top of page
 LocationLondon, United Kingdom
 Abstract The annual Controlling Cancer Summit in an international academic event with plenty of opportunity  for networking and debate. In an informal setting, this meeting will bring you up to date with current research and thinking regarding screening, prevention and treatment in  this ever-growing field.  Presenting at this event, we will have a variety of clinicians, academics and members of the pharmaceutical industry; we encourage presentations from  the wide spectrum of cancer research, development and healthcare professionals.
42.EMBO Conference — Cellular signalling and cancer therapy
 Dates 27 May 2016 → 31 May 2016
[ID=739348] Go to top of page
 LocationCavtat, Croatia
 Topics Signal Transduction | Molecular Medicine
 Related subject(s) Molecular Biology
43.American Society of Clinical Oncology 2016 Annual Meeting
 Dates 03 Jun 2016 → 07 Jun 2016
[ID=651378] Go to top of page
 LocationChicago, United States
 Abstract Attendees of the 2016 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
44.IARC 50th Anniversary Conference
 Dates 07 Jun 2016 → 10 Jun 2016
[ID=739839] Go to top of page
 LocationLyon, France
 Abstract A scientific conference to celebrate the 50th anniversary of the International Agency for Research on Cancer In keeping with IARC’s mission over the past five decades, this anniversary conference will feature presentations on research into the global occurrence, etiology, and prevention of cancer as well as the implementation of prevention and early detection. The multidisciplinary conference will bridge cancer research through to cancer control and policy, providing comprehensive state-of-the-art summaries from keynote speakers as well as a look forward at future research priorities.
45.WIN symposium 2016
 Dates 27 Jun 2016 → 28 Jun 2016
[ID=760117] Go to top of page
 LocationParis, France
 Abstract The Worldwide Innovative Networking (WIN) Consortium invites you to join the WIN 2016 Symposium, to be held in Paris, June 27-28, 2016. This Symposium will be the next in the successful series of annual meetings dedicated to precision cancer medicine.
46.SOHO 2016 — Society of Hematologic Oncology Fourth Annual Meeting
 Dates 07 Sep 2016 → 10 Sep 2016
[ID=764363] Go to top of page
 LocationHouston, Texas, United States
 Abstract The Society of Hematologic Oncology Fourth Annual Meeting is scheduled for September 7-10, 2016 at the Westin Galleria and Oaks in Houston, Texas.
 Topics hematology, oncology, soho, hematologic malignancies, society of hematologic oncology
 Contact Melinda White; Phone: [1 (281) 364-7387 ext 216]; Email:
 Related subject(s) Hematology; Clinical trials
47.CoBrCa — 2nd World Congress on Controversies in Breast Cancer
 Dates 08 Sep 2016 → 11 Sep 2016
[ID=765192] Go to top of page
 LocationBarcelona, Spain
 Abstract CoBRCA will continue the tradition of directly addressing controversial issues in breast cancer faced by clinicians in their daily practice. The congress will address these key issues in the format of debates and discussions, allowing ample time for speaker-participant interaction. In addition to the key issues in medical oncology, surgery, radiation oncology and supportive care, CoBrCa will address controversial issues in radiology, pathology and reconstruction, with presentations, debates and discussions.
 Topics breast cancer, oncology
 Contact Ilana Rabinoff-Sofer; Phone: [+972 73 706 6954]; Email:
48.ESMO 2016 Congress
 Dates 07 Oct 2016 → 11 Oct 2016
[ID=760765] Go to top of page
 LocationCopenhagen, Denmark
 Abstract The annual ESMO Congress is the premier scientific platform to present your oncology research and as such, the ultimate learning experience for Congress attendees. Across disciplines and across cultures, ESMO bridges the gap between researchers, clinicians and patients and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
49.17th World Conference on Lung Cancer 2016
 Dates 04 Dec 2016 → 07 Dec 2016
[ID=649302] Go to top of page
 LocationVienna, Austria
 Abstract The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. 
 Related subject(s) Pulmonology
50.Cell Symposia: Hallmarks of Cancer
 Dates 11 Dec 2016 → 13 Dec 2016
[ID=761460] Go to top of page
 LocationGhent, Belgium
 Abstract As one of the most investigated areas in biomedical research, the cancer field is rapidly advancing by translating biological insights towards better detection and therapeutics, including molecular classifications as well as immunotherapies. In the era of the genetically informed, emerging concepts in cancer biology and oncology research are colliding into precision medicine. In order to accelerate the development of personalized cancer therapies and further translate fundamental discoveries into the clinic, there must be open lines of communication at the interface between the lab and the clinic. Our goal in organizing this Cell Symposium, Hallmarks of Cancer, is to convene global leaders in the cancer research arena to enhance our understanding of the key aspects of cancer and how to promote translation of this knowledge into the development of targeted therapeutics. We aim to provide a high-impact, high-profile forum for exchanging ideas and establishing a dialogue amongst clinicians, scientists and drug development companies. Symposium themes: Tumor metabolism, Tumor heterogeneity, Tumor immunology and immunotherapy, Personalized cancer therapy, Metastasis and the tumor microenvironment.
 Related subject(s) Biology
51.American Society of Clinical Oncology 2017 Annual Meeting
 Dates 02 Jun 2017 → 06 Jun 2017
[ID=651355] Go to top of page
 LocationChicago, United States
 Abstract Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
52.Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
 Dates 18 Oct 2017 → 21 Oct 2017
[ID=764446] Go to top of page
 LocationBrisbane, Australia
 Topics Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
 Contact Vivien Lietze; Phone: [+4930204590]; Email:
 Related subject(s) Dermatology

Last updated: 30 October 2097